R9-PCP

General Information


DRACP ID  DRACP05449

Peptide Name   R9-PCP

Sequence  RRRRRRRRRXDEXLI

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  Φ=L-2-naphthylalanine; X(10)=miniPEG, 8-amino-3,6-dioxaoctanoic acid; X(13)=Pcap, phosphocoumaryl aminopropionic acid

Chiral  L



Physicochemical Information


Formula  C75H140N40O16

Absent amino acids  ACFGHKMNPQSTVWY

Common amino acids  R

Mass  232806

Pl  12.8

Basic residues  9

Acidic residues  2

Hydrophobic residues  2

Net charge  7

Boman Index  -13997

Hydrophobicity  -261.33

Aliphatic Index  52

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24896852

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2248

DRACP is developed by Dr.Zheng's team.